Jonathan L. Ditta
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Stress Responses and Cortisol, Neurotransmitter Receptor Influence on Behavior, Neuroscience and Neuropharmacology Research, Receptor Mechanisms and Signaling, Synthesis and Biological Evaluation
Most-Cited Works
- → 2-Aryl-2,2-difluoroacetamide FKBP12 Ligands: Synthesis and X-ray Structural Studies(2001)103 cited
- → A Strategy to Minimize Reactive Metabolite Formation: Discovery of (S)-4-(1-Cyclopropyl-2-methoxyethyl)-6-[6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino]-5-oxo-4,5-dihydropyrazine-2-carbonitrile as a Potent, Orally Bioavailable Corticotropin-Releasing Factor-1 Receptor Antagonist(2009)54 cited
- → High-Throughput Fluorescence Polarization Method for Identification of FKBP12 Ligands(2002)49 cited
- → Fluoresceinated FKBP12 ligands for a high-throughput fluorescence polarization assay(2000)42 cited
- → In Vitro Intrinsic Clearance-Based Optimization ofN3-Phenylpyrazinones as Corticotropin-Releasing Factor-1 (CRF1) Receptor Antagonists(2009)38 cited
- → Aminotriazine 5-HT7 antagonists(2004)36 cited
- → Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain(2017)36 cited
- → Conformationally Restricted Homotryptamines. 2. Indole Cyclopropylmethylamines as Selective Serotonin Reuptake Inhibitors(2005)33 cited
- → Synthesis, Structure−Activity Relationships, and In Vivo Evaluation ofN3-Phenylpyrazinones as Novel Corticotropin-Releasing Factor-1 (CRF1) Receptor Antagonists(2009)33 cited
- → Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors(2009)29 cited